Complementary Medicine Use before and 1 Year Following Genetic Testing for BRCA1/2 Mutations
Open Access
- 1 January 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (1) , 70-75
- https://doi.org/10.1158/1055-9965.epi-05-0646
Abstract
Purpose: We explored change in complementary and alternative medicine (CAM) use by unaffected women and cancer survivors from enrollment into a randomized BRCA1/2 testing program to CAM use 1 year following results disclosure.Keywords
This publication has 26 references indexed in Scilit:
- A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancerEuropean Journal Of Cancer, 2005
- Prevention and Management of Hereditary Breast CancerJournal of Clinical Oncology, 2005
- Dietary patterns and the risk of postmenopausal breast cancerInternational Journal of Cancer, 2005
- Bilateral Prophylactic Oophorectomy and Ovarian Cancer Screening Following BRCA1/BRCA2 Mutation TestingJournal of Clinical Oncology, 2003
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Effect of family history, obesity and exercise on breast cancer risk among postmenopausal womenInternational Journal of Cancer, 2003
- Factors implicated in the decision whether or not to join the tamoxifen trial in women at high familial risk of breast cancerPsycho‐Oncology, 2000
- BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomesPublished by American Medical Association (AMA) ,1996
- Mechanisms in Multiple Risk Factor Interventions: Smoking, Physical-Activity, and Dietary-Fat Intake Among Manufacturing WorkersPreventive Medicine, 1994
- Psychological Distress and Surveillance Behaviors of Women With a Family History of Breast CancerJNCI Journal of the National Cancer Institute, 1992